Volume 43, Issue 6
7 February 2022
Cover image
Cover image
During cardiometabolic based chronic disease, dysglycemia and excess adipocity induce a differentiate imbalance in the bone marrow that contribute to overproduction of inflammatory cells and impaired mobilization of progenitor cells that mediate endogenous mechanisms for vessel repair and regeneration.
ISSN 0195-668X
EISSN 1522-9645
Issue navigation
Volume 43, Issue 6, 7 February 2022
Focus Issue on Vascular Biology and Medicine
Issue @ A Glance
New therapeutic targets in the prevention of atherosclerotic cardiovascular disease
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 435–439, https://doi.org/10.1093/eurheartj/ehac014
CardioPulse
The ‘Ten Commandments’ of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 440–441, https://doi.org/10.1093/eurheartj/ehab853
Fasting small vessels to prevent microvascular ageing? The experience of a microvascular research group working in the shadow of the leaning tower
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 442–444, https://doi.org/10.1093/eurheartj/ehab475
The future of the cardiovascular conference landscape
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 445–447, https://doi.org/10.1093/eurheartj/ehab659
CardioPulse
Weekly Journal Scan
Age-independent benefits of blood pressure lowering: are they applicable to all patients?
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 448–449, https://doi.org/10.1093/eurheartj/ehab825
State of the Art Review
Diabetes and Metabolic Disorders
Vascular repair and regeneration in cardiometabolic diseases
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 450–459, https://doi.org/10.1093/eurheartj/ehab758
Vascular Biology and Medicine
Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 460–473, https://doi.org/10.1093/eurheartj/ehab756
Fast Track Clinical Research
Diabetes and Metabolic Disorders
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 474–484, https://doi.org/10.1093/eurheartj/ehab777
Editorial
Bringing FIDELITY to the estimate of treatment effects of finerenone in chronic kidney disease due to type 2 diabetes
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 485–487, https://doi.org/10.1093/eurheartj/ehab827
Clinical Research
Vascular Biology and Medicine
Tubulin-folding cofactor E deficiency promotes vascular dysfunction by increased endoplasmic reticulum stress
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 488–500, https://doi.org/10.1093/eurheartj/ehab222
Editorial
Identification of a novel therapeutic target in vascular dysfunction: a showcase of reverse and forward translational research linking bench to bedside
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 501–503, https://doi.org/10.1093/eurheartj/ehab263
Translational Research
Vascular Biology and Medicine
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 504–514, https://doi.org/10.1093/eurheartj/ehab631
Editorial
Platelet-derived MMP-2 in the prevention of plaque formation: how many strokes is par?
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 515–517, https://doi.org/10.1093/eurheartj/ehab665
Vascular Biology and Medicine
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 518–533, https://doi.org/10.1093/eurheartj/ehab644
Editorial
The promise of the gut metabolite propionate for a novel and personalized lipid-lowering treatment
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 534–537, https://doi.org/10.1093/eurheartj/ehab723
Discussion Forum
How to identify which patients should not have a systolic blood pressure target of <120 mmHg
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 538–539, https://doi.org/10.1093/eurheartj/ehab552
Importance of pulse pressure at low systolic blood pressure
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Page 540, https://doi.org/10.1093/eurheartj/ehab553
Cardiovascular Flashlight
Highly enhanced macrophage-driven inflammatory signatures on giant coronary artery aneurysms: a 3D-rendered 18F-FDG-PET/CT imaging assessment
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Pages 541–542, https://doi.org/10.1093/eurheartj/ehab463
Aortic jet lesion: new insights with multimodal imaging
European Heart Journal, Volume 43, Issue 6, 7 February 2022, Page 543, https://doi.org/10.1093/eurheartj/ehab021
